Blood tubes potassium ethylenediaminetetraacetic acid in comparison to calcium disodium ethylenediaminetetraacetic acid and disodium ethylenediaminetetraacetic acid for calcific band keratopathy

血液试管中含钾乙二胺四乙酸与含钙乙二胺四乙酸二钠和乙二胺四乙酸二钠的试管在钙化带状角膜病变中的比较

阅读:3

Abstract

This study aims to report a case of dense calcific band keratopathy (CBK) treated with calcium disodium ethylenediaminetetraacetic acid (CaNa2EDTA) and dipotassium ethylenediaminetetraacetic acid (K2EDTA). A 12-year-old female with chronic Vogt-Koyanagi-Harada (VKH) syndrome and glaucoma presented with dense CBK in her right eye (OD). We used CaNa2EDTA followed by K2EDTA to enhance the chelation process. No adverse events were observed, and 1-year posttreatment, the patient showed no recurrence. Our findings suggest that K2EDTA can complement and enhance the effect of CaNa2EDTA, offering a cost-effective and readily available alternative. We acknowledge that the simultaneous use of two chelating agents in the same case may limit the conclusiveness of our findings regarding their individual efficacy. However, based on previous reports, we believe the significant clearing effect observed is primarily attributable to K2EDTA rather than a combined effect.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。